Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.278
+0.005 (1.72%)
Nov 21, 2024, 12:02 PM EST - Market open

Aptose Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-35.8-51.21-41.82-65.35-55.24-26.28
Upgrade
Depreciation & Amortization
0.420.470.530.620.610.61
Upgrade
Loss (Gain) From Sale of Assets
0.08-0.02---
Upgrade
Stock-Based Compensation
1.413.655.2112.9521.442.3
Upgrade
Other Operating Activities
0.130.09-0.027.520.090.39
Upgrade
Change in Accounts Payable
-0.98-0.287.61-0.470.210.65
Upgrade
Change in Other Net Operating Assets
-2.432.69-3.841.43-1.010.77
Upgrade
Operating Cash Flow
-37.18-44.59-32.32-43.3-33.89-21.56
Upgrade
Capital Expenditures
--0.03-0.02-0.21-0.08-0.1
Upgrade
Investment in Securities
1.949.9930.09-3512.71-17.27
Upgrade
Investing Cash Flow
1.969.9630.07-35.2112.63-17.37
Upgrade
Issuance of Common Stock
27.636.910.120.2358.98103.89
Upgrade
Other Financing Activities
-0.17----0.17-0.44
Upgrade
Financing Cash Flow
27.466.910.120.2358.81103.45
Upgrade
Foreign Exchange Rate Adjustments
-00-00.010.010.02
Upgrade
Net Cash Flow
-7.76-27.72-2.14-78.2837.5564.54
Upgrade
Free Cash Flow
-37.18-44.62-32.35-43.52-33.97-21.66
Upgrade
Free Cash Flow Per Share
-2.65-6.61-5.26-7.33-6.23-6.48
Upgrade
Levered Free Cash Flow
-23.76-25.82-16.6-26.03-13.14-12.17
Upgrade
Unlevered Free Cash Flow
-23.76-25.82-16.6-26.03-13.14-12.17
Upgrade
Change in Net Working Capital
2.97-2.81-4.32-1.520.26-1.81
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.